Live Breaking News & Updates on Halozyme Therapeutics Daily
Stay updated with breaking news from Halozyme therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Halozyme Therapeutics (NASDAQ:HALO) Releases FY24 Earnings Guidance dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Halozyme Therapeutics (NASDAQ:HALO) Issues FY24 Earnings Guidance tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Gallacher Capital Management LLC boosted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 85.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,403 shares of the biopharmaceutical company’s stock after acquiring an additional 5,245 shares during the period. […] ....
HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Tuesday, Benzinga reports. HC Wainwright currently has a $50.00 price target on the biopharmaceutical company’s stock. HALO has been the topic of a number of other reports. The Goldman Sachs Group dropped their price objective […] ....
Halozyme Therapeutics (NASDAQ:HALO – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a $50.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 27.23% from the company’s […] ....